Apnimed, Inc. (APMD) Balance Sheet
APMD balance sheet, 2025
December 31, 2025 · U.S. dollars$72.9M assets = $445.7M liabilities + −$372.8M equity
Liabilities exceed assets: shareholders’ equity is negative (−$372.8M).
Both columns are drawn to the same scale: what APMD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
APMD financial health
Descriptive bands, not a rating. Fiscal 2025.
APMD balance sheet trends, 2024–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $109.2M2024 | $72.9M2025 | −33.3%/yr | |
| Total liabilities | $357.8M2024 | $445.7M2025 | +24.5%/yr | |
| Shareholders’ equity | −$248.6M2024 | −$372.8M2025 | — | |
| Cash & short-term investments | $68.3M2024 | $41.9M2025 | −38.7%/yr | |
| Working capital | $30.9M2024 | −$65.8M2025 | −$96.7M | |
| Book value per share | −$6.242024 | −$9.362025 | — | |
| Current ratio | 1.732024 | 0.412025 | −1.32 | |
| Shares outstanding | 39.8M2024 | 39.8M2025 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
APMD assets
APMD liabilities and equity
APMD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
APMD balance sheet
| 2025 | 2024 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $41.9M | $68.3M |
| Cash & equivalents | $41.9M | $68.3M |
| Receivables | $959,000 | $1.1M |
| Inventory | $0 | $0 |
| Other current assets | $2.2M | $3.8M |
| Total current assets | $45.1M | $73.2M |
| Property, plant & equipment (net) | $901,000 | $1.2M |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $26.9M | $34.8M |
| Total assets | $72.9M | $109.2M |
| Liabilities | ||
| Accounts payable | $1.8M | $3.6M |
| Total current liabilities | $110.9M | $42.4M |
| Long-term debt | $40.6M | $0 |
| Lease obligations | $873,000 | $1.1M |
| Other long-term liabilities | $294.1M | $315.5M |
| Total liabilities | $445.7M | $357.8M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$397.3M | −$269.2M |
| Total shareholders' equity | −$372.8M | −$248.6M |
| Key figures | ||
| Total debt | $40.6M | — |
| Net cash (debt) | $1.2M | — |
| Working capital | −$65.8M | $30.9M |
| Tangible book value | −$372.8M | −$248.6M |
| Book value per share | −$9.36 | −$6.24 |
| Shares outstanding | 39.8M | 39.8M |
| Current ratio | 0.41 | 1.73 |
| Quick ratio | 0.39 | 1.64 |
| Equity / assets | −511.6% | −227.6% |
| Jun '26 | Mar '26 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $172.8M | $328.9M |
| Cash & equivalents | $172.8M | $328.9M |
| Receivables | $690,000 | $876,000 |
| Inventory | $0 | $0 |
| Other current assets | $11.3M | $2.2M |
| Total current assets | $184.8M | $332.0M |
| Property, plant & equipment (net) | $10.7M | $10.6M |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $24,000 | $24,000 |
| Total assets | $195.5M | $342.6M |
| Liabilities | ||
| Accounts payable | $6.6M | $3.0M |
| Total current liabilities | $35.6M | $38.4M |
| Long-term debt | $79.6M | $46.1M |
| Lease obligations | $750,000 | $812,000 |
| Other long-term liabilities | $256.5M | $555,000 |
| Total liabilities | $371.6M | $85.0M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$203.7M | −$187.0M |
| Total shareholders' equity | −$176.2M | $257.6M |
| Key figures | ||
| Total debt | $79.6M | $46.1M |
| Net cash (debt) | $93.2M | $282.8M |
| Working capital | $149.2M | $293.6M |
| Tangible book value | −$176.2M | $257.6M |
| Book value per share | −$4.42 | $6.47 |
| Shares outstanding | 39.8M | 39.8M |
| Current ratio | 5.19 | 8.65 |
| Quick ratio | 4.88 | 8.59 |
| Debt / equity | — | 0.18 |
| Equity / assets | −90.1% | 75.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
APMD financial position
At the end of fiscal 2025 (December 31, 2025), Apnimed had total assets of $72.9 million (down 33.3% from a year earlier), total liabilities of $445.7 million and shareholders' equity of -$372.8 million. It held $41.9 million in cash and short-term investments against $40.6 million of debt, a net cash position of $1.2 million. Its current ratio was 0.41. In the latest quarter (ended June 30, 2026) total assets were $195.5 million and equity -$176.2 million.
Related: APMD income statement, APMD cash flow statement, APMD key metrics. See the APMD stock overview for the latest quote and news.
APMD balance sheet FAQ
What are Apnimed's total assets?
Apnimed reported total assets of $72.9 million at the end of fiscal 2025 (December 31, 2025), compared with $109.2 million a year earlier.
How much debt does Apnimed have?
Apnimed had $40.6 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does Apnimed have?
Apnimed held $41.9 million in cash and short-term investments at the end of fiscal 2025; with $40.6 million of debt that is net cash of $1.2 million.
What is Apnimed's book value?
Apnimed's shareholders' equity (book value) was -$372.8 million at the end of fiscal 2025, or −$9.36 per share.
What is Apnimed's current ratio?
Apnimed had current assets of $45.1 million and current liabilities of $110.9 million, a current ratio of 0.41 (current liabilities exceed current assets).